Skip to content

Clinical trials

Terminated Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Terminated Clear all

272 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20022
20034
20045
20052
20064
200714
200815
200915
201015
201112
201211
20137
201412
201510
201614
201716
201820
201921
202012
202119
202215
202317
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated272

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Assistance Publique - Hôpitaux de Paris7
Stanford University6
Chinese University of Hong Kong4
Incyte Corporation4
M.D. Anderson Cancer Center4
Case Comprehensive Cancer Center3
Mayo Clinic3
Pfizer3
Rennes University Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular272
Liver Neoplasms63
Carcinoma, Renal Cell20
Neoplasms19
Carcinoma, Non-Small-Cell Lung18
Stomach Neoplasms18
Colorectal Neoplasms16
Melanoma16
Cholangiocarcinoma13
Squamous Cell Carcinoma of Head and Neck13

Trials

Showing 1 to 25 of 272. Each trial links to its page on Pharma Observatory.

172 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.